Trials / Completed
CompletedNCT02778919
Late Phase II Clinical Study of KLH-2109 in Patients With Endometriosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy, safety, and dose-response relationship of KLH-2109 compared to placebo in Japanese patients with endometriosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KLH-2109 | |
| DRUG | Placebo | |
| DRUG | Leuprorelin acetate |
Timeline
- Start date
- 2016-05-09
- Primary completion
- 2018-03-23
- Completion
- 2018-03-23
- First posted
- 2016-05-20
- Last updated
- 2019-06-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02778919. Inclusion in this directory is not an endorsement.